沃爾核材(002130.SZ):終止樂庭智聯籌劃創業板分拆上市和新三板掛牌
格隆匯3月21日丨沃爾核材(002130.SZ)公佈,公司(以下簡稱“公司”)於2024年3月21日召開了第七屆董事會第十四次會議,以9票同意、0票反對、0票棄權審議通過了《關於終止樂庭智聯籌劃創業板分拆上市和新三板掛牌的議案》,公司董事會同意終止控股子公司惠州樂庭智聯科技股份有限公司(簡稱“樂庭智聯”)籌劃分拆至創業板上市,並終止樂庭智聯在全國中小企業股份轉讓系統(簡稱“新三板”)掛牌事宜。
經綜合考慮市場環境變化、控股子公司樂庭智聯自身經營情況,為統籌安排公司及控股子公司的業務發展和資本運作規劃,經與相關方充分溝通與審慎論證,公司決定終止樂庭智聯籌劃分拆至創業板上市,並終止樂庭智聯新三板掛牌事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.